JPS5645470A - Cholesterol synthesization inhibitor substituted pyranones - Google Patents

Cholesterol synthesization inhibitor substituted pyranones

Info

Publication number
JPS5645470A
JPS5645470A JP11186880A JP11186880A JPS5645470A JP S5645470 A JPS5645470 A JP S5645470A JP 11186880 A JP11186880 A JP 11186880A JP 11186880 A JP11186880 A JP 11186880A JP S5645470 A JPS5645470 A JP S5645470A
Authority
JP
Japan
Prior art keywords
cholesterol
synthesization
dihydroxy acids
phenyl
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP11186880A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0257550B2 (enExample
Inventor
Kee Uiraado Arubuin
Shii Nobuero Furederitsuku
Efu Hofuman Uiriamu
Jiee Kuragoo Jiyuniya Edowaado
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of JPS5645470A publication Critical patent/JPS5645470A/ja
Publication of JPH0257550B2 publication Critical patent/JPH0257550B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C67/347—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by addition to unsaturated carbon-to-carbon bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP11186880A 1979-08-17 1980-08-15 Cholesterol synthesization inhibitor substituted pyranones Granted JPS5645470A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6757479A 1979-08-17 1979-08-17

Publications (2)

Publication Number Publication Date
JPS5645470A true JPS5645470A (en) 1981-04-25
JPH0257550B2 JPH0257550B2 (enExample) 1990-12-05

Family

ID=22076933

Family Applications (1)

Application Number Title Priority Date Filing Date
JP11186880A Granted JPS5645470A (en) 1979-08-17 1980-08-15 Cholesterol synthesization inhibitor substituted pyranones

Country Status (24)

Country Link
EP (1) EP0024348B1 (enExample)
JP (1) JPS5645470A (enExample)
KR (1) KR840002170B1 (enExample)
AT (1) ATE16487T1 (enExample)
AU (1) AU6108580A (enExample)
CA (1) CA1137989A (enExample)
CS (1) CS219921B2 (enExample)
DD (1) DD152558A5 (enExample)
DE (1) DE3071230D1 (enExample)
DK (1) DK353680A (enExample)
ES (1) ES494301A0 (enExample)
FI (1) FI802582A7 (enExample)
GR (1) GR69938B (enExample)
HU (1) HU182190B (enExample)
IE (1) IE50789B1 (enExample)
IL (1) IL60751A (enExample)
MA (1) MA18929A1 (enExample)
NO (1) NO155491C (enExample)
NZ (1) NZ194557A (enExample)
PL (2) PL127979B1 (enExample)
PT (1) PT71672B (enExample)
YU (1) YU207180A (enExample)
ZA (1) ZA805016B (enExample)
ZW (1) ZW19080A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440927A (en) * 1981-06-19 1984-04-03 Merck & Co., Inc. Process for preparing inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase via a chiral synthon
EP0068038B1 (en) * 1981-06-29 1985-09-25 Merck & Co. Inc. (+)-(4r,6s)-(e)-6-(2-(4'-fluoro-3,3',5-trimethyl-(1,1'-biphenyl)-2-yl)ethenyl)-3,4,5,6-tetrahydro-4-hydroxy-2h-pyran-2-one, a process for preparing and a pharmaceutical composition containing the same
US4588820A (en) * 1984-06-11 1986-05-13 Merck & Co., Inc. Process for epimerization at C6 of 3,4,5,6-tetrahydro-2H-pyran-2-one
US4647576A (en) * 1984-09-24 1987-03-03 Warner-Lambert Company Trans-6-[2-(substitutedpyrrol-1-yl)alkyl]-pyran-2-one inhibitors of cholesterol synthesis
DE3615620A1 (de) * 1986-05-09 1987-11-12 Hoechst Ag 4(r)-substituierte 6(s)-phenoxymethyl-, 6(s)-(beta)-phenylaethyl-und 6(s)-(beta)-styryl-tetrahydropyran-2-one, ein hochstereoselektives verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
US4897490A (en) * 1987-02-25 1990-01-30 Bristol-Meyers Company Antihypercholesterolemic tetrazole compounds
US4898949A (en) * 1987-02-25 1990-02-06 Bristol-Myers Company Intermediates for the preparation of antihypercholesterolemic tetrazole compounds
US5169976A (en) * 1987-11-25 1992-12-08 Pfizer Inc. N-(biphenylmethyl)-3-hydroxyglutaramic acid and derivatives as hypocholesterolemic agents
FI94339C (fi) 1989-07-21 1995-08-25 Warner Lambert Co Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi
US5093363A (en) * 1989-08-22 1992-03-03 Shionogi & Co., Ltd. 2,4,6-substituted phenol derivatives
JP3171931B2 (ja) * 1992-06-02 2001-06-04 高砂香料工業株式会社 （Ｒ）−（−）−４−シアノ−３−ヒドロキシ酪酸ｔ−ブチルエステル及びその製造方法
IL129871A (en) * 1994-05-06 2003-11-23 Pharmacia & Upjohn Inc Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
RU2563831C1 (ru) * 2014-10-13 2015-09-20 Федеральное государственное бюджетное учреждение науки Иркутский институт химии им. А.Е. Фаворского Сибирского отделения Российской академии наук Применение протатран 4-хлор-2-метилфеноксиацетата (хлоркрезацина) для угнетения активности холестеролэстеразы
WO2016161085A1 (en) 2015-04-01 2016-10-06 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5559180A (en) * 1978-10-30 1980-05-02 Sankyo Co Ltd 4-hydroxy-2-pyrone ring compound, its preparation, and remedy for hyperlipemia comprising it as active constituent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53147073A (en) * 1977-05-24 1978-12-21 Sankyo Co Ltd Mevalonolactone derivatives

Also Published As

Publication number Publication date
IE801732L (en) 1981-02-17
HU182190B (en) 1983-12-28
MA18929A1 (fr) 1981-04-01
PL226285A1 (enExample) 1981-03-27
IL60751A0 (en) 1980-10-26
NO155491C (no) 1987-04-08
PL132249B1 (en) 1985-02-28
KR830003465A (ko) 1983-06-20
CS219921B2 (en) 1983-03-25
PT71672A (en) 1980-09-01
PT71672B (en) 1982-01-22
IE50789B1 (en) 1986-07-23
ZA805016B (en) 1982-03-31
EP0024348B1 (en) 1985-11-13
JPH0257550B2 (enExample) 1990-12-05
IL60751A (en) 1985-04-30
DD152558A5 (de) 1981-12-02
AU6108580A (en) 1981-02-19
NO802431L (no) 1981-02-18
NZ194557A (en) 1984-09-28
FI802582A7 (fi) 1981-02-18
ES8106152A1 (es) 1981-07-16
NO155491B (no) 1986-12-29
CA1137989A (en) 1982-12-21
DE3071230D1 (en) 1985-12-19
ES494301A0 (es) 1981-07-16
GR69938B (enExample) 1982-07-21
EP0024348A1 (en) 1981-03-04
DK353680A (da) 1981-02-19
YU207180A (en) 1983-02-28
ZW19080A1 (en) 1982-03-17
PL127979B1 (en) 1983-12-31
KR840002170B1 (ko) 1984-11-26
ATE16487T1 (de) 1985-11-15

Similar Documents

Publication Publication Date Title
JPS5645470A (en) Cholesterol synthesization inhibitor substituted pyranones
HU910647D0 (en) Process for producing substituted derivatives of 2-pyridone and pyride-2-thione
ES8503686A1 (es) Procedimiento de preparar derivados de penicilina.
ATE121743T1 (de) Pyridazinon-derivate.
HUT46895A (en) Process for production of new 5-lipoxigenase bicyclic compounds with inhibiation effect
LTIP603A (en) Novel esters, method for the preparation thereof and pharmaceutical composition
GR3017022T3 (en) Pyridone derivatives, process for their preparation, novel obtained intermediates, their use as medicines and pharmaceutical compositions containing them.
AU549554B2 (en) 2,3-trimethylene-, tetramethylene- and pentamethylene- morpholines
HUT45262A (en) New process for producing penicillin derivatives
HU904596D0 (en) Process for producing lankacidine-carbaminate derivatives